Viewing Study NCT00868595


Ignite Creation Date: 2025-12-24 @ 1:36 PM
Ignite Modification Date: 2026-02-26 @ 11:53 PM
Study NCT ID: NCT00868595
Status: COMPLETED
Last Update Posted: 2019-10-08
First Post: 2009-03-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: MTD Study of Vaccine BP-GMAX-CD1 Plus AP1903 to Treat Castrate Resistant Prostate Cancer
Sponsor: Bellicum Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module